These should be the most vulnerable hospital patients in the UK, who cannot generate an antibody response to Covid offered a new drug Ronapreve from Monday. The treatment, approved only last month, uses a pair of laboratory-produced antibodies to attack the virus. It was used as part of an experimental drug given by US President Donald Trump last year when he contracted the virus.
0 Comments